Hello from Brussels! 🇧🇪 From Oct 28-30, the Scientific Advisory Board and Committee of IMMUcan met at @EORTC headquarters. We engaged in meaningful discussions on our progress and explored future research directions. Exciting times ahead!
IMMUcan (Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts) is an @IHIEurope (#IMI2) project proposing an inclusive immuno-oncology platform.

